Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Pearson

Showing results (381-390 of 578) with videos related to

Pageof 58
Sort By:
Genome Research|December 3, 2014
A novel role for the Pol I transcription factor UBTF in maintaining genome stability through the regulation of highly transcribed Pol II genesElaine Sanij, Jeannine Diesch, Analia Lesmana, et al.
Cell Death Discovery|September 25, 2025
Exploiting dysregulated iron homeostasis to eradicate persistent high-grade serous ovarian cancerCarmelo Cerra, Madeleine R C Tancock, Niko Thio, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2018
Ribosomal DNA copy loss and repeat instability in ATRX-mutated cancersMaheshi Udugama, Elaine Sanij, Hsiao P J Voon, et al.
Nature Communications|March 29, 2017
Inhibiting the system x<sub>C</sub><sup>-</sup>/glutathione axis selectively targets cancers with mutant-p53 accumulationDavid S Liu, Cuong P Duong, Sue Haupt, et al.
Journal for Immunotherapy of Cancer|July 26, 2024
Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapyHaider Al-Janabi, Katy Moyes, Richard Allen, et al.
Blood|January 29, 2021
Impaired ribosome biogenesis checkpoint activation induces p53-dependent MCL-1 degradation and MYC-driven lymphoma deathAna Domostegui, Suresh Peddigari, Carol A Mercer, et al.
Blood|February 14, 2013
Combined inhibition of PI3K-related DNA damage response kinases and mTORC1 induces apoptosis in MYC-driven B-cell lymphomasJake Shortt, Benjamin P Martin, Andrea Newbold, et al.
International Journal of Cancer|December 16, 2017
Palbociclib synergizes with BRAF and MEK inhibitors in treatment naïve melanoma but not after the development of BRAF inhibitor resistanceClaire A Martin, Carleen Cullinane, Laura Kirby, et al.
Cancer Discovery|October 23, 2015
Combination Therapy Targeting Ribosome Biogenesis and mRNA Translation Synergistically Extends Survival in MYC-Driven LymphomaJennifer R Devlin, Katherine M Hannan, Nadine Hein, et al.
Cancer Discovery|May 17, 2019
First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation StudyAmit Khot, Natalie Brajanovski, Donald P Cameron, et al.
Pageof 58

Showing results (381-390 of 578) with videos related to

Sort By:
Pageof 58
Genome Research|December 3, 2014
A novel role for the Pol I transcription factor UBTF in maintaining genome stability through the regulation of highly transcribed Pol II genesElaine Sanij, Jeannine Diesch, Analia Lesmana, et al.
Cell Death Discovery|September 25, 2025
Exploiting dysregulated iron homeostasis to eradicate persistent high-grade serous ovarian cancerCarmelo Cerra, Madeleine R C Tancock, Niko Thio, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2018
Ribosomal DNA copy loss and repeat instability in ATRX-mutated cancersMaheshi Udugama, Elaine Sanij, Hsiao P J Voon, et al.
Nature Communications|March 29, 2017
Inhibiting the system x<sub>C</sub><sup>-</sup>/glutathione axis selectively targets cancers with mutant-p53 accumulationDavid S Liu, Cuong P Duong, Sue Haupt, et al.
Journal for Immunotherapy of Cancer|July 26, 2024
Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapyHaider Al-Janabi, Katy Moyes, Richard Allen, et al.
Blood|January 29, 2021
Impaired ribosome biogenesis checkpoint activation induces p53-dependent MCL-1 degradation and MYC-driven lymphoma deathAna Domostegui, Suresh Peddigari, Carol A Mercer, et al.
Blood|February 14, 2013
Combined inhibition of PI3K-related DNA damage response kinases and mTORC1 induces apoptosis in MYC-driven B-cell lymphomasJake Shortt, Benjamin P Martin, Andrea Newbold, et al.
International Journal of Cancer|December 16, 2017
Palbociclib synergizes with BRAF and MEK inhibitors in treatment naïve melanoma but not after the development of BRAF inhibitor resistanceClaire A Martin, Carleen Cullinane, Laura Kirby, et al.
Cancer Discovery|October 23, 2015
Combination Therapy Targeting Ribosome Biogenesis and mRNA Translation Synergistically Extends Survival in MYC-Driven LymphomaJennifer R Devlin, Katherine M Hannan, Nadine Hein, et al.
Cancer Discovery|May 17, 2019
First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation StudyAmit Khot, Natalie Brajanovski, Donald P Cameron, et al.
Pageof 58